Cargando…

Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study

Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compli...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaya, Ajan Maheswaran, Harries, Anthony D., Rahman, Anisur, Khogali, Mohammed, Chinnakali, Palanivel, Gopal, Bipin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228986/
https://www.ncbi.nlm.nih.gov/pubmed/35736982
http://dx.doi.org/10.3390/tropicalmed7060104
_version_ 1784734619767144448
author Jaya, Ajan Maheswaran
Harries, Anthony D.
Rahman, Anisur
Khogali, Mohammed
Chinnakali, Palanivel
Gopal, Bipin
author_facet Jaya, Ajan Maheswaran
Harries, Anthony D.
Rahman, Anisur
Khogali, Mohammed
Chinnakali, Palanivel
Gopal, Bipin
author_sort Jaya, Ajan Maheswaran
collection PubMed
description Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compliance and factors associated with poor compliance in DM persons attending selected primary care government facilities in Kerala during the COVID-19 pandemic. Persons registered with DM for >6 months were consecutively interviewed between August and September 2021. Poor compliance was defined as answering “No” to one or more of three questions related to access and intake of medication two weeks prior to and the day before the interview. Factors independently associated with poor compliance were assessed using adjusted prevalence ratios (aPr) and 95% confidence intervals. Of the 560 DM persons included, 209 (37%) exhibited poor compliance. Factors associated with poor compliance were age 19–45 years (aPr 1.4, 1.1–1.9); inability to be blood glucose tested during the COVID-19 pandemic (aPr 3.6, 2.9–4.3); not having COVID-19 (aPr 1.4, 1.0–1.9); and being double vaccinated against COVID-19 (aPr 1.4, 1.1–2.0). Focused attention must be paid to these groups to improve medication compliance and prevent DM complications and severe COVID-19-related disease.
format Online
Article
Text
id pubmed-9228986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92289862022-06-25 Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study Jaya, Ajan Maheswaran Harries, Anthony D. Rahman, Anisur Khogali, Mohammed Chinnakali, Palanivel Gopal, Bipin Trop Med Infect Dis Article Compliance with medication in persons with diabetes mellitus (DM) has been a challenge during the COVID-19 pandemic, leading to poor glycemic control and higher risk of complications. In the state of Kerala, India, 20–25% of adults have DM. Our cross-sectional study aimed to assess medication compliance and factors associated with poor compliance in DM persons attending selected primary care government facilities in Kerala during the COVID-19 pandemic. Persons registered with DM for >6 months were consecutively interviewed between August and September 2021. Poor compliance was defined as answering “No” to one or more of three questions related to access and intake of medication two weeks prior to and the day before the interview. Factors independently associated with poor compliance were assessed using adjusted prevalence ratios (aPr) and 95% confidence intervals. Of the 560 DM persons included, 209 (37%) exhibited poor compliance. Factors associated with poor compliance were age 19–45 years (aPr 1.4, 1.1–1.9); inability to be blood glucose tested during the COVID-19 pandemic (aPr 3.6, 2.9–4.3); not having COVID-19 (aPr 1.4, 1.0–1.9); and being double vaccinated against COVID-19 (aPr 1.4, 1.1–2.0). Focused attention must be paid to these groups to improve medication compliance and prevent DM complications and severe COVID-19-related disease. MDPI 2022-06-14 /pmc/articles/PMC9228986/ /pubmed/35736982 http://dx.doi.org/10.3390/tropicalmed7060104 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jaya, Ajan Maheswaran
Harries, Anthony D.
Rahman, Anisur
Khogali, Mohammed
Chinnakali, Palanivel
Gopal, Bipin
Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
title Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
title_full Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
title_fullStr Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
title_full_unstemmed Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
title_short Compliance with Medication amongst Persons with Diabetes Mellitus during the COVID-19 Pandemic, Kerala, India: A Cross Sectional Study
title_sort compliance with medication amongst persons with diabetes mellitus during the covid-19 pandemic, kerala, india: a cross sectional study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228986/
https://www.ncbi.nlm.nih.gov/pubmed/35736982
http://dx.doi.org/10.3390/tropicalmed7060104
work_keys_str_mv AT jayaajanmaheswaran compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy
AT harriesanthonyd compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy
AT rahmananisur compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy
AT khogalimohammed compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy
AT chinnakalipalanivel compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy
AT gopalbipin compliancewithmedicationamongstpersonswithdiabetesmellitusduringthecovid19pandemickeralaindiaacrosssectionalstudy